// App-Quantinova.ai

: FIRST-IN-HUMAN CLINICAL TRIAL OF THE AUTOLOGOUS CD7-CART CELLS FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

Researchers

Presenter

  • Mingzhi Zhang

Principal Investigators

  • Lei Zhang

  • Huimin Meng

  • Ling Li

  • Xin Li

  • Xinhua Wang

  • Zhenchang Sun

  • Hui Yu

  • Zhaoming Li

  • Feifei Nan

  • Yu Chang

  • Zhiyuan Zhou

  • Jiaqin Yan

  • Jiwei Li

  • Min Wang

  • Fengtao You

  • Dan Chen

  • Yu-Sheng Chen

  • Guifang Pan

  • Hanying Xu

  • Bozhen Zhang

  • Lin Yang

Medical Centers

  • Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

  • The Hematology Center, Cyrus Tang Medical Institute, Soochow University, Suzhou, China

  • Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

  • PersonGen-Anke Cellular Therapeutics Co., Ltd., Hefei, China

  • PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • First-In-Human

Phase

  • I

Study Id's

  • NCT04004637

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved